How Korea's split between prescribing and dispensing remade clinics, pharmacies and the drug bill
Korea's 2000 reform requiring doctors to prescribe and pharmacists to dispense reorganized the country's medical streetscape, shifted where money flows in health care and left some of its original goals only partly met.
Walk into almost any mid-sized building in a Korean city and the pattern is familiar: an internal medicine clinic, a pediatrician and an ear, nose and throat practice stacked on the upper floors, and a pharmacy at street level by the entrance. That arrangement is not an accident of real estate. It is the physical imprint of a policy known in Korean as uiyak bunop, the separation of prescribing from dispensing, which took effect in 2000 and reorganized how Koreans get medicine and how doctors and pharmacists earn their living.
Before the reform, the two professions overlapped heavily. Clinics routinely dispensed drugs on site, and pharmacists could hand out a wide range of medicines, including antibiotics and steroids, often without any prescription at all. For patients this was convenient and cheap. For policymakers it was a problem on two fronts. Unsupervised access was widely blamed for heavy antibiotic use and resistance, and doctors who dispensed had a financial incentive to prescribe more, because the gap between the official reimbursement price of a drug and what clinics actually paid wholesalers was a significant source of income.
The reform tried to cut both knots at once: doctors would diagnose and prescribe, pharmacists would dispense, and neither would profit from the other’s role. Its introduction was among the most contentious episodes in Korean health policy. Doctors staged a series of strikes and clinic closures around 2000, arguing that losing drug margins would make many practices unviable. The government ultimately raised consultation fees to bring them back, and the added costs contributed to a serious financial squeeze on the National Health Insurance system in the years that followed. The settlement shaped the system’s economics for decades, shifting physician income away from drugs and toward visit volume.
The most visible consequence was geographic. Because patients now had to carry a prescription somewhere, pharmacies migrated to wherever prescriptions were written. So-called door-front pharmacies clustered around large hospitals, whose outpatient dispensing was largely moved outside, and ground-floor pharmacies became anchors of clinic buildings. Pharmacy locations next to busy practices came to command high rents and premiums, while neighborhood pharmacies far from clinics lost much of their footing. Critics argue the arrangement created quiet interdependence between particular clinics and particular pharmacies, the very kind of linkage the reform was meant to sever, and regulators have periodically had to police arrangements that blur the line.
On drug costs, the record is mixed. The reform removed the most direct profit motive for prescribing, but money found other channels. Pharmaceutical companies competing to get their products written into prescriptions turned to rebates and inducements aimed at doctors, prompting Korea to adopt rules that penalize both the givers and the receivers of such payments. Because doctors typically prescribe by brand and pharmacists face restrictions on substituting cheaper equivalents, the system has tended to favor branded generics that compete on relationships rather than price, and debates over ingredient-name prescribing recur without resolution. Pharmaceutical spending has long been regarded as a relatively large share of Korean health expenditure by international standards.
The reform also left lasting friction between the professions. Pharmacists guard their dispensing role and resisted the later decision to allow a limited range of household medicines, such as basic fever and cold remedies, to be sold in convenience stores. Doctors, in turn, have pushed back against proposals that would expand pharmacists’ authority. Each side reads the original bargain as a line not to be crossed.
What endures is a system that is accessible and fast, where a clinic visit and a filled prescription can be completed in under an hour, but one whose incentives still reward volume. The prescription split succeeded in changing who hands patients their pills. Whether it changed how many pills are handed out, and at what price, remains a more open question.